Page last updated: 2024-10-27

fluconazole and Hypertrophy, Left Ventricular

fluconazole has been researched along with Hypertrophy, Left Ventricular in 1 studies

Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.

Hypertrophy, Left Ventricular: Enlargement of the LEFT VENTRICLE of the heart. This increase in ventricular mass is attributed to sustained abnormal pressure or volume loads and is a contributor to cardiovascular morbidity and mortality.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Shoieb, SM1
Alammari, AH1
Levasseur, J1
Silver, H1
Dyck, JRB1
El-Kadi, AOS1

Other Studies

1 other study available for fluconazole and Hypertrophy, Left Ventricular

ArticleYear
Ameliorative Role of Fluconazole Against Abdominal Aortic Constriction-Induced Cardiac Hypertrophy in Rats.
    Journal of cardiovascular pharmacology, 2022, 06-01, Volume: 79, Issue:6

    Topics: Animals; Cardiomegaly; Constriction; Fluconazole; Hydroxyeicosatetraenoic Acids; Hypertrophy, Left V

2022